Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
HYGEIA HEALTHCARE HOLDINGS CO., LIMITED Financials Hygeia Healthcare Holdings Co., Limited
Equities
6078
KYG4712E1035
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 42.55 HKD | -3.30% | -12.99% | -24.02% | |
| Dec. 01 | Hygeia Healthcare to Buy Chinese Hospital for 46 Million Yuan | MT |
| Aug. 30 | Hygeia Healthcare's Profit Climbs in H1; Shares Drop 3% | MT |
Valuation
| Fiscal Period : December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 25 383 | 24 573 | 30 502 | 24 550 | - | - |
| Enterprise Value (EV) 1 | 22 803 | 25 098 | 30 937 | 24 018 | 23 476 | 22 623 |
| P/E ratio | 108x | 56,0x | 64,2x | 32,2x | 24,2x | 19,2x |
| Yield | 0,29% | - | 0,30% | 0,68% | 0,92% | 1,03% |
| Capitalization / Revenue | 18,1x | 10,6x | 9,54x | 5,86x | 4,46x | 3,61x |
| EV / Revenue | 16,3x | 10,8x | 9,68x | 5,73x | 4,27x | 3,32x |
| EV / EBITDA | 60,4x | 35,4x | 37,7x | 20,5x | 15,6x | 12,1x |
| EV / FCF | -784x | -103x | 335x | 48,4x | 36,6x | 19,8x |
| FCF Yield | -0,13% | -0,97% | 0,30% | 2,07% | 2,73% | 5,04% |
| Price to Book | 5,95x | 5,51x | 6,18x | 4,16x | 3,59x | 3,07x |
| Nbr of stocks (in thousands) | 618 000 | 618 000 | 616 724 | 631 524 | - | - |
| Reference price 2 | 41,1 | 39,8 | 49,5 | 38,9 | 38,9 | 38,9 |
| Announcement Date | 3/29/21 | 3/30/22 | 3/20/23 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period : December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 1 086 | 1 402 | 2 315 | 3 196 | 4 189 | 5 498 | 6 808 |
| EBITDA 1 | - | 378 | 708 | 820 | 1 171 | 1 507 | 1 865 |
| EBIT 1 | - | 300 | 594 | 667 | 974 | 1 288 | 1 631 |
| Operating Margin | - | 21,4% | 25,6% | 20,9% | 23,3% | 23,4% | 24,0% |
| Earnings before Tax (EBT) 1 | - | 253 | 573 | 643 | 955 | 1 272 | 1 612 |
| Net income 1 | 39,8 | 170 | 441 | 477 | 753 | 999 | 1 257 |
| Net margin | 3,66% | 12,1% | 19,1% | 14,9% | 18,0% | 18,2% | 18,5% |
| EPS 2 | - | 0,38 | 0,71 | 0,77 | 1,21 | 1,61 | 2,02 |
| Free Cash Flow 1 | - | -29,1 | -243 | 92,3 | 496 | 641 | 1 140 |
| FCF margin | - | -2,08% | -10,5% | 2,89% | 11,8% | 11,7% | 16,7% |
| FCF Conversion (EBITDA) | - | - | - | 11,3% | 42,3% | 42,5% | 61,1% |
| FCF Conversion (Net income) | - | - | - | 19,3% | 65,9% | 64,1% | 90,7% |
| Dividend per Share 2 | - | 0,12 | - | 0,15 | 0,26 | 0,36 | 0,40 |
| Announcement Date | 6/16/20 | 3/29/21 | 3/30/22 | 3/20/23 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period : December | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1 526 | 1 669 | 1 759 | 2 121 | 2 323 | 2 619 |
| EBITDA | - | - | - | - | - | - |
| EBIT 1 | 315 | 352 | 420 | 503 | 558 | 606 |
| Operating Margin | 20,6% | 21,1% | 23,9% | 23,7% | 24,0% | 23,1% |
| Earnings before Tax (EBT) | 307 | - | 412 | - | - | - |
| Net income | 224 | - | 334 | - | - | - |
| Net margin | 14,7% | - | 19,0% | - | - | - |
| EPS 2 | - | 0,41 | 0,53 | 0,60 | 0,69 | 0,75 |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 8/31/22 | 3/20/23 | 8/29/23 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period : December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 525 | 435 | - | - | - |
| Net Cash position 1 | - | 2 580 | - | - | 532 | 1 074 | 1 928 |
| Leverage (Debt/EBITDA) | - | - | 0,74x | 0,53x | - | - | - |
| Free Cash Flow 1 | - | -29,1 | -243 | 92,3 | 496 | 641 | 1 140 |
| ROE (net income / shareholders' equity) | - | 8,37% | 10,1% | 10,2% | 13,8% | 15,6% | 16,9% |
| Shareholders' equity 1 | - | 2 033 | 4 362 | 4 695 | 5 459 | 6 387 | 7 439 |
| ROA (Net income/ Total Assets) | - | 4,92% | 7,75% | 6,85% | 9,50% | 11,0% | 11,7% |
| Assets 1 | - | 3 457 | 5 694 | 6 964 | 7 928 | 9 051 | 10 712 |
| Book Value Per Share 2 | - | 6,91 | 7,21 | 8,00 | 9,35 | 10,8 | 12,7 |
| Cash Flow per Share 2 | - | 0,66 | 0,69 | 1,11 | 1,60 | 1,86 | 2,38 |
| Capex 1 | - | 325 | 669 | 607 | 505 | 490 | 494 |
| Capex / Sales | - | 23,2% | 28,9% | 19,0% | 12,1% | 8,90% | 7,26% |
| Announcement Date | 6/16/20 | 3/29/21 | 3/30/22 | 3/20/23 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
38.99CNY
Average target price
62.3CNY
Spread / Average Target
+59.79%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -24.02% | 3 554 M $ | |
| -31.88% | 21 232 M $ | |
| +9.71% | 17 459 M $ | |
| -11.21% | 11 820 M $ | |
| -6.75% | 11 022 M $ | |
| +23.80% | 9 626 M $ | |
| -24.00% | 7 215 M $ | |
| +8.53% | 6 563 M $ | |
| +9.67% | 6 187 M $ | |
| +14.08% | 6 061 M $ |
- Stock
- Equities
- Stock Hygeia Healthcare Holdings Co., Limited - Hong Kong Stock Exchange
- Financials Hygeia Healthcare Holdings Co., Limited
